#Japan #Tokyo #CPC Corporation #JOA Annual Meeting #Dr. Saito

Enhancing Regenerative Medicine at the 98th JOA Annual Meeting

CPC Corporation, headquartered in Chiyoda, Tokyo, is set to once again highlight its commitment to regenerative medicine at the 98th Japanese Orthopaedic Association (JOA) Annual Meeting. This year's event will feature a noteworthy luncheon seminar, marking CPC's sixth consecutive year of collaboration. The seminar, scheduled for May 23, 2025, will provide vital insights into cutting-edge developments in cell therapy for osteoarthritis.

Event Details

• - Date: May 23, 2025
• - Time: 12:30 PM - 1:40 PM
• - Location: JP Tower Hall & Conference, 4th Floor, Conference Room A (310 seats)

The luncheon seminar will be chaired by Dr. Toru Ogata, a distinguished professor and head of the Rehabilitation Department at the University of Tokyo's Faculty of Medicine. The feature presentation will be delivered by Dr. Taku Saito, an associate professor in the Orthopaedics at the University of Tokyo Graduate School of Medicine. His talk, titled "Clinical Applications and Mechanisms of Cell Therapy for Osteoarthritis," promises to offer valuable insights into emerging treatment modalities.

To participate in the seminar, attendees are encouraged to check the Japanese Orthopaedic Association's website for more information: JOA 2025.

Exhibition

In addition to the seminar, CPC Corporation will also showcase its innovations at its dedicated booth during the event. Visitors can find CPC at the Tokyo International Forum, Hall E, from May 22 to 25, 2025, at booth number E-32. This exhibition will emphasize CPC’s cutting-edge services, which support regenerative medicine from introduction to operation. The company is particularly proud of its licensed cell culture processing facility, which adheres to the safety provisions of Japan’s Regenerative Medicine Safety Assurance Act. This facility allows CPC to perform entrusted cell culture processing for medical institutions.

About CPC Corporation

CPC Corporation is widely recognized as a leader in supporting the field of regenerative medicine. Under the guidance of CEO Keita Inoue, the company is dedicated to advancing healing and recovery through innovative practices and regulatory compliance.

Company Information

• - Headquarters: 3-4 Kanda Surugadai, Chiyoda, Tokyo
• - Phone: 03-3518-5666
• - Website: CPC Corporation

As the JOA Annual Meeting approaches, CPC Corporation stands at the forefront of regenerative medicine, exemplifying its commitment to improving patient outcomes through collaboration and scientific innovation.